Stay updated on Influenza Virus Challenge Trial for Monoclonal Antibody
Sign up to get notified when there's something new on the Influenza Virus Challenge Trial for Monoclonal Antibody page.

Latest updates to the Influenza Virus Challenge Trial for Monoclonal Antibody page
- Check6 days agoChange DetectedAdded London, United Kingdom as a study location and updated the recruitment status.SummaryDifference0.3%

- Check13 days agoNo Change Detected
- Check34 days agoChange DetectedThe page now includes a government-funding and operating-status notice and marks a new version (v3.2.0), replacing the previous v3.1.0.SummaryDifference4%

- Check41 days agoChange Detected- Added new chemical categories and contact numbers; updated revision to v3.1.0. - Removed several drug-safety and saline-related terms and older revision v3.0.2.SummaryDifference1%

- Check56 days agoChange DetectedMinor update: version updated from v3.0.1 to v3.0.2; 'Back to Top' removed. No substantive changes to core content.SummaryDifference0.3%

- Check63 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.3%

- Check70 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location, as well as new content related to drug safety and various types of pharmaceutical solutions. Notably, previous references to specific locations and flu shots have been removed.SummaryDifference2%

Stay in the know with updates to Influenza Virus Challenge Trial for Monoclonal Antibody
Enter your email address, and we'll notify you when there's something new on the Influenza Virus Challenge Trial for Monoclonal Antibody page.